The global neurological disorder diagnostics market size was valued at USD 14,162.3 million in 2021 and is poised to grow at a significant CAGR of 7.5% during the forecast period 2022-28. Neurological biomarkers are chemicals found in the blood and cerebral spinal fluid (CSF) that help diagnose and track the evolution of brain illnesses. Genetic mutations, metabolite levels, brain imaging, and...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian